Cargando…
A Novel Small Peptide Inhibitor of NFκB, RH10, Blocks Oxidative Stress-Dependent Phenotypes in Cancer
BACKGROUND: The RH domain of GRK5 is an effective modulator of cancer growth through the inhibition of NFκB activity. The aim of this study was to identify the minimum effective sequence of RH that is still able to inhibit tumor growth and could be used as a peptide-based drug for therapy. METHODS:...
Autores principales: | Gambardella, Jessica, Ciccarelli, Michele, Del Giudice, Carmine, Fiordelisi, Antonella, De Rosa, Matteo, Sala, Marina, Pacelli, Roberto, Campiglia, Pietro, Trimarco, Bruno, Iaccarino, Guido, Sorriento, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247396/ https://www.ncbi.nlm.nih.gov/pubmed/30524659 http://dx.doi.org/10.1155/2018/5801807 |
Ejemplares similares
-
Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice
por: Cipolletta, Ersilia, et al.
Publicado: (2019) -
Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis
por: Gambardella, Jessica, et al.
Publicado: (2020) -
Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications
por: Gambardella, Jessica, et al.
Publicado: (2018) -
Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure
por: Ciccarelli, Michele, et al.
Publicado: (2020) -
Dual role of GRK5 in cancer development and progression
por: Gambardella, J, et al.
Publicado: (2016)